UTHR Financial Facts
Operating income: 238.6MCost of product sales: 23.6M
See Full Income Statement
Accumulated other comprehensive loss: -16.8M
Marketable investments: 79.6M
See Full Balance Sheet
United Therapeutics Corp. (UTHR) Earnings
|
Expand Research on UTHR
Next EPS Date | 5/1/24 | EPS Growth Rate | +18.9% |
---|---|---|---|
Average EPS % Beat Rate | +6.1% | Revenue Growth Rate | +22.7% |
Average % Move 1-Wk after EPS | -0.1% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
5/1/24 | Q124 | N/A | $5.78 | N/A | N/A | $621.93M | N/A | N/A | N/A | ||
2/21/24 | Q423 | $4.36 | $4.44 | -$0.08 | $614.7M | $575.1M | N/A | Details | |||
11/1/23 | Q323 | $5.38 | $5.15 | +$0.23 | $609.4M | $587.9M | N/A | Details | |||
8/2/23 | Q223 | $5.24 | $4.57 | +$0.67 | $596.5M | $524.18M | N/A | Details | |||
5/3/23 | Q123 | $4.86 | $4.54 | +$0.32 | $506.9M | $512.69M | N/A | Details | |||
2/22/23 | Q422 | $2.67 | $4.72 | -$2.05 | $491.5M | $519.21M | N/A | Details | |||
11/2/22 | Q322 | $4.91 | $4.06 | +$0.85 | $516M | $493.81M | N/A | Details | |||
8/3/22 | Q222 | $2.41 | $4.38 | -$1.97 | $466.9M | $460.67M | N/A | Details |